AUM Biosciences to Speak at ACCESS CHINA Boston Forum

May 16th, 2023 (Shanghai) — We are glad to announce that Vishal Doshi, the CEO of AUM Biosciences, has been invited as panel guest speaker at ACCESS CHINA Boston Forum on June 4th. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biotech industry.

About the speaker

Vishal Doshi

Chairman & CEO, AUM Biosciences

Vishal Doshi is the Founder of AUM Biosciences and also serves as the Chairman of AUM’s Board of Directors. A pharmacist by training, he also has an extensive experience in structuring and managing global deals worth over US$4 billion in drug development with major pharmaceuticals, and biotech companies. His extensive experience comes from major drug development organisations such as Quintiles, ICON, and many more reputed global enterprises.

As one of the founders of AUM, his joint experience with the other founder also includes a 145M USD PE deal with a major pharmaceutical company that resulted in achieving POC for 3 major oncology drugs currently on the market with peak sales of over 4B USD combined.

Vishal is a key opinion leader for the South Korean Government’s affiliated institution KHIDI. Under Vishal’s leadership, AUM successfully transitioned from a pre-clinical to a clinical stage company and developed a portfolio of transformative cancer medicines within 12 months of inception. He was awarded the 2019 Asia-Pacific Biotech Entrepreneurial Company of The Year by Frost and Sullivan. Vishal was also nominated as a Young Global Leader by the World Economic Forum for Class of 2021.

Vishal has passionately championed the potential benefits of precision medicine and healthcare reform for patients. Vishal received a B. Pharma from University of Mumbai and holds a master’s degree in Pharmaceutical Sciences from Kingston University, UK.

About ACCESS CHINA Boston Forum

“ACCESS CHINA – Boston Forum @BIO” is scheduled to be held on June 4th and June 13th-15th, 2023, in Boston and online, respectively. This event is expected to be the largest Asia-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”. During the forum, we will cover a range of key topics include drug innovation, market trends, partnership models, and best practices for successful collaborations, etc.

Conference Name: ACCESS CHINA – Boston Forum @BIO

Date & Time: June 4, Sun. (Boston) and June 13-15 (Online)

Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception

Scale: Expected 1000 participants Online, 150 participants onsite; 100 company roadshows

Participants: Pharma/Biotech senior management and BDs, investors.

View more information at https://biotochina.org/

关于药通中国-波士顿论坛

“ACCESS CHINA 药通中国-波士顿论坛@BIO”将于2023年6月4-15日在波士顿及线上举行的。此次论坛将是BIO Convention 2023大会期间最大的亚洲主题交流活动。在过去3年时间，药通中国已成功举办13届线上线下活动，帮助近千家公司在药通平台上展出。

大会名称：药通中国-波士顿论坛@BIO

大会日期：2023.6.4（周日，波士顿） 2023.6.13-15（线上）

大会内容：主题演讲、圆桌讨论、海内外优质项目路演、睿智医药-药通中国招待晚宴

大会规模：预计线上1000参会者；线下150参会者; 100场公司路演